Titan Pharmaceuticals files F-4 for proposed reverse merger with TalenTec Sdn. Bhd.

TITAN PHARMACEUTICALS INC

Filed registration statement on Form F-4 for business combination with TalenTec.
Transaction expected to close in Q3 2025, subject to stockholder approval.
Reverse merger previously announced on August 19, 2024.
Black Titan Corporation is the new holding company for the combined entity.

item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.